Detection of Actionable Mutation Status in Advanced Non-Small Cell Lung Cancer by Next-Generation Sequencing of Circulating Tumor DNA

被引：1
作者：
Yang, Y. [1 ]
Song, X. [1 ]
Guo, W. [1 ]
机构：
[1] Shanxi Med Univ, Canc Hosp, Shanxi Canc Hosp, Dept Pulm Oncol, Taiyuan, Shanxi, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
EGFR; NSCLC; ctDNA;
D O I：
10.1016/j.jtho.2018.08.1185
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-130
引用
收藏
页码：S715 / S715
页数：1
相关论文
共 50 条
  • [31] Predictive value of tumor mutation burden (TMB) with targeted next-generation sequencing in immuno-checkpoint inhibitors for non-small cell lung cancer (NSCLC)
    Ma, Xiaoting
    Zhang, Yujian
    Wang, Shan
    Yu, Jing
    JOURNAL OF CANCER, 2021, 12 (02): : 584 - 594
  • [32] Comparison of targeted next generation sequencing assays in non-small cell lung cancer patients
    Drejeriene, Ieva
    Gruode, Jurate
    Cicenas, Saulius
    Loizides, Charalambos
    Eliades, Alexia
    Achilleos, Achilleas
    Kypri, Elena
    Tsangaras, Kyriakos
    Ioannides, Marios
    Koumbaris, George
    Stanciute, Diana
    Krasauskas, Arnoldas
    Patsalis, Philippos C.
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [33] Prognostic value of circulating tumor DNA using target next-generation sequencing in extensive-stage small-cell lung cancer
    Zhang, Jiexia
    Zhou, Ningning
    Deng, Huojin
    Chen, Xin
    Chen, Qunqing
    Wang, Qiongyao
    Sun, Lei
    Wen, Yang
    Cao, Xiaolong
    Luo, Zhiqiang
    Zhang, Jian
    Zhu, Weiliang
    Guo, Linlang
    LUNG CANCER, 2023, 178 : 11 - 19
  • [34] Next-generation sequencing of non-small cell lung cancer using a customized, targeted sequencing panel: Emphasis on small biopsy and cytology
    DiBardino, David M.
    Rawson, David W.
    Saqi, Anjali
    Heymann, Jonas J.
    Pagan, Carlos A.
    Bulman, William A.
    CYTOJOURNAL, 2017, 13
  • [35] Analytical and clinical validation of a custom 15-gene next-generation sequencing panel for the evaluation of circulating tumor DNA mutations in patients with advanced non-small-cell lung cancer
    Chow, Yock Ping
    Abidin, Norziha Zainul
    Kow, Ken Siong
    Tho, Lye Mun
    Wong, Chieh Lee
    PLOS ONE, 2022, 17 (10):
  • [36] Next Generation Sequencing-Based Profiling of Cell Free DNA in Patients with Advanced Non-Small Cell Lung Cancer: Advantages and Pitfalls
    Abate, Riziero Esposito
    Frezzetti, Daniela
    Maiello, Monica Rosaria
    Gallo, Marianna
    Camerlingo, Rosa
    De Luca, Antonella
    De Cecio, Rossella
    Morabito, Alessandro
    Normanno, Nicola
    CANCERS, 2020, 12 (12) : 1 - 17
  • [37] Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
    Yang, Jialiang
    Hui, Yan
    Zhang, Yanxiang
    Zhang, Minghui
    Ji, Binbin
    Tian, Geng
    Guo, Yangqiang
    Tang, Min
    Li, Lianxing
    Guo, Bella
    Ma, Tonghui
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [38] DETECTION OF CIRCULATING TUMOUR CELLS IN ADVANCED NON-SMALL CELL LUNG CANCER
    Fanning, Michael
    Lehman, Margot
    Mai, Tao
    Horwood, Keith
    Murphy, Michelle
    Mccafferey, Elizabeth
    Jovanovic, Lidija
    Upham, John
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S477 - S477
  • [39] A Comparative Analysis of Genomic Alterations by Tumor Tissue and Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer
    Woo, G.
    Kim, S. H.
    Suh, K. J.
    Kim, Y. J.
    Chung, J.
    Lee, B.
    Kwon, N.
    Seo, J.
    Lee, J. S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S706 - S706
  • [40] Mutational profile by targeted next generation sequencing of non-small cell lung cancer in the Mexican population
    Hernandez-Pedro, Norma
    Soca-Chafre, Giovanny
    Alaez-Verson, Carmen
    Carrillo-Sanchez, Karol
    Aviles-Salas, Alejandro
    Vergara, Edgar
    Arrieta, Oscar
    SALUD PUBLICA DE MEXICO, 2019, 61 (03): : 308 - 317
12345